3D Bioprinting Solutions, 3D Biotek, and Advanced BioMatrixAcquiring Major Share of 3D Bio-Printing Market

Posted on 2018-08-13 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Aug-13 — /EPR Network/ —According to Goldstein Research, the global 3D bio-printing market is segmented based on technology and by applications. Application segment is further bifurcated into pharmaceutical, tissue and organ regeneration, bones and 3D cell culture. North America and Europe dominate the global 3D bio-printing market with approximately 60% market share. However, it is expected that Asia Pacific region is poised to take lead in 3D bioprinting technology in future. The Asia Pacific is the key region for the potential adoption of 3D bioprinting technology, dominated by the South Korea, Japan and China, which currently contributes to the 21% of the share in the global 3D bio-printing market.

The world is facing the huge shortage of organs available for lifesaving transplants. For instance, in U.K an individual have to wait an average of 944 days for a kidney transplant. There is the similar shortage of liver, lungs and other organs. The shortage of transplant tissues and organs is estimated to be the major cause for the death in America with around 900,000 deaths a years or one third of all deaths in the U.S. These rising number of deaths can be prevented or delayed by the printed or engineered tissue transplants, with the growing demand the growth opportunity for 3D bio-printing technology is endless.

“Global 3D Bio-Printing Market Outlook, 2016-2024” covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, the competitive analysis includes the in-depth analysis of the major players and leaders in the healthcare industry.

The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of industry 3D bioprinter manufacturers, suppliers, and distributors, pharmaceutical & biotechnology companies, cosmetic product manufacturers, healthcare institutions, clinical centres, medical research laboratories and academic medical centres and universities to analyze the future prospects of the overall healthcare industry.

Request Report Sample @https://www.goldsteinresearch.com/request-sample/3d-bioprinting-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Segmentation

Global 3D Bio-Printing Market Segmentation can be classified on the basis of:

By Technology

Inkjet-Based Bio Printing
Extrusion Based Bio Printing
Laser-Based Bio Printing

By Applications

Pharmaceuticals
Tissue and Organ Regeneration
Bones
3D Cell Culture
other

By Geography

North America (US, Canada) 3D Bio-Printing Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) 3D Bio-Printing Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) 3D Bio-Printing Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Latin America (Brazil, Mexico and Rest of Latin America) 3D Bio-Printing Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) 3D Bio-Printing Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Browse Full Report: https://www.goldsteinresearch.com/report/3d-bio-printing-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Trend: 3D Bioprinting Attracts Investors

BIOLIFE4D, a medical technology manufacturer in USA has registered a USD 50 million initial public offering with the SEC under Regulation A+ rules and signed a laboratory service agreement with Northwestern University in order to access world-class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities to, make the technology faultless in order to fabricate viable organ replacement a safe, accessible and affordable reality.

Driver: Shortage Of Organs And Rising Need For Transplants

According to the World Health Organization (WHO), more than 119,873 organs were transplanted which is increasing by 1.81% annually. Shortage of organs and rising need for transplants has significantly bolstered the demand for 3D bio-printed organs to overcome the shortage of organs for transplants.

Challenge: Huge Investments at Nascent Stage Of 3D Bio-Printing

However, being in its nascent stage huge investments and the high cost of devices hinders the growth of 3d bioprinting market. But, once 3D Bioprinting of human tissues and organs become commercially feasible, patients will have access to these organs, printed using the size and organic structure they need. As healthcare cost drops, this innovation will play an important role in both emerging and developed economies.

“3D Bio-Printing Market Analysis” has been prepared based on an in-depth market analysis from industry experts. The market research report covers the competitive landscape and current position of major players in the market space. The report also includes Porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. The global 3D bio-printing market report also recognizes value chain analysis to understand the cost differentiation to provide the competitive advantage to the existing and new entry players.

About Goldstein Research

Based in the U.S., Goldstein Research is a young business consulting and market research firm with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa.

We strive to realize a strong brand presence globally through our quality research and forecasting solutions. With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand.

Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare market reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Matched content

Editor’s pick